nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adequacy of samples obtained via percutaneous core-needle rebiopsy for EGFR T790M molecular analysis in patients with non-small cell lung cancer following acquired resistance to first-line therapy: A systematic review and meta-analysis
|
Poudel, Bibhav |
|
|
29 |
C |
p. |
artikel |
2 |
Adherence to surveillance colonoscopy guidelines in patients following curative-intent colorectal cancer resection
|
Stephens, Kyle |
|
|
29 |
C |
p. |
artikel |
3 |
Advances in Oncoanaesthesia and Cancer Pain
|
Thomas, Mary |
|
|
29 |
C |
p. |
artikel |
4 |
Aging-associated immune system changes in multiple myeloma: The dark side of the moon.
|
Visram, Alissa |
|
|
29 |
C |
p. |
artikel |
5 |
Association of the neutrophil-to-lymphocyte ratio with brain metastases in Hispanic breast cancer patients.
|
Cacho-Díaz, Bernardo |
|
|
29 |
C |
p. |
artikel |
6 |
Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer
|
Ottestad, Anine Larsen |
|
|
29 |
C |
p. |
artikel |
7 |
A systematic review and meta-analysis on the efficacy and safety of metformin as adjunctive therapy among women with metastatic breast cancer
|
Lusica, Patricia Marie M. |
|
|
29 |
C |
p. |
artikel |
8 |
Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review
|
Zhuansun, Yongxun |
|
|
29 |
C |
p. |
artikel |
9 |
Comprehending fibroblast growth factor receptor like 1: Oncogene or tumor suppressor?
|
Aprajita, |
|
|
29 |
C |
p. |
artikel |
10 |
Concurrent versus sequential chemoradiotherapy for unresectable locally advanced stage III non-small cell lung cancer: Retrospective analysis in a single United Kingdom cancer centre
|
Spencer, Alice |
|
|
29 |
C |
p. |
artikel |
11 |
Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study
|
A, Kartolo |
|
|
29 |
C |
p. |
artikel |
12 |
Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer
|
Brady, Lauren |
|
|
29 |
C |
p. |
artikel |
13 |
Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myeloma
|
Ravi, Gayathri |
|
|
29 |
C |
p. |
artikel |
14 |
David versus Goliath: Radiotheranostic nanomedicine as a weapon against melanoma
|
Filippi, Luca |
|
|
29 |
C |
p. |
artikel |
15 |
Discovery of a novel anti PD-L1 X TIGIT bispecific antibody for the treatment of solid tumors.
|
Xiao, Yang |
|
|
29 |
C |
p. |
artikel |
16 |
Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment: An illustrative case report
|
McFarland, Taylor Ryan |
|
|
29 |
C |
p. |
artikel |
17 |
Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer.
|
Laerum, Dan |
|
|
29 |
C |
p. |
artikel |
18 |
Format (2D vs 3D) and media effect target expression and response of patient-derived and standard NSCLC lines to EGFR inhibitors
|
Kaur, Gurmeet |
|
|
29 |
C |
p. |
artikel |
19 |
Gene expression profiling in melanoma: A view from the clinic
|
Bollard, S.M. |
|
|
29 |
C |
p. |
artikel |
20 |
Granulocyte-colony stimulating factor-associated aortitis in cancer: A systematic literature review
|
Hoshina, Hideko |
|
|
29 |
C |
p. |
artikel |
21 |
Immunotherapy in multiple myeloma
|
Jadoon, Yamna |
|
|
29 |
C |
p. |
artikel |
22 |
Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas
|
Ezer, Nicole |
|
|
29 |
C |
p. |
artikel |
23 |
Invited commentary on “Neoadjuvant pertuzumab plus trastuzumab in combination with anthracycline-free chemotherapy regimen in patients with HER2 positive breast cancer: Real-world data from a single center in India”.
|
Michael, Co |
|
|
29 |
C |
p. |
artikel |
24 |
Is skipped nodal metastasis a phenomenon of cutaneous melanoma?
|
El-Omar, Omar |
|
|
29 |
C |
p. |
artikel |
25 |
Laboratory biomarkers of an effective antitumor immune response. Clinical significance.
|
Malkova, A.M. |
|
|
29 |
C |
p. |
artikel |
26 |
Mortality in cutaneous malignant melanoma and its association with Neutrophil-to-Lymphocyte ratio.
|
Pinto-Paz, Mirian Elizabeth |
|
|
29 |
C |
p. |
artikel |
27 |
Neoadjuvant pertuzumab plus trastuzumab in combination with anthracycline- free chemotherapy regimen in patients with HER2 positive breast cancer–Real-world data from a single center in India
|
Arora, Shalabh |
|
|
29 |
C |
p. |
artikel |
28 |
Oncology drug-companion diagnostic combinations
|
Jørgensen, Jan Trøst |
|
|
29 |
C |
p. |
artikel |
29 |
Oncolytic virotherapy – Forging its place in the immunomodulatory paradigm for Multiple Myeloma
|
Cook, Joselle |
|
|
29 |
C |
p. |
artikel |
30 |
Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.
|
Burks, Eric J. |
|
|
29 |
C |
p. |
artikel |
31 |
Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLC
|
Kurata, Takayasu |
|
|
29 |
C |
p. |
artikel |
32 |
Possible association between SP-C mutations and lung cancer: Two case reports and review of literature
|
Darawshy, Fares |
|
|
29 |
C |
p. |
artikel |
33 |
Primary Hodgkin's Lymphoma of bone in 7-year-old- an exceptional case report of youngest child in literature
|
Siddiqui, Durr-e- Amna |
|
|
29 |
C |
p. |
artikel |
34 |
Prioritising breast cancer theranostics: A current medical longing in oncology
|
Pandey, Prem N. |
|
|
29 |
C |
p. |
artikel |
35 |
Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide
|
Watanabe, Hirofumi |
|
|
29 |
C |
p. |
artikel |
36 |
Relationship between the three-dimensionally measured tumor doubling time of lung cancer and underlying interstitial lung disease: A retrospective case-control study
|
Yamamichi, Takashi |
|
|
29 |
C |
p. |
artikel |
37 |
Rural vs urban inequalities in stage at diagnosis for lung cancer
|
Shah, Bashir Daud |
|
|
29 |
C |
p. |
artikel |
38 |
Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients
|
de Kock, Remco |
|
|
29 |
C |
p. |
artikel |
39 |
Signet ring cell carcinoma of the gastrointestinal tract: National trends on treatment effects and prognostic outcomes
|
Franko, Jan |
|
|
29 |
C |
p. |
artikel |
40 |
Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications
|
Osawa, Yuko |
|
|
29 |
C |
p. |
artikel |
41 |
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.
|
Facondo, Giuseppe |
|
|
29 |
C |
p. |
artikel |
42 |
Study of clinicopathological factors and their impact on survival in phyllodes tumour of breast at tertiary care cancer centre in India
|
Sanjay, Singh |
|
|
29 |
C |
p. |
artikel |
43 |
Supportive care in multiple myeloma: Current practices and advances
|
Miceli, Teresa S. |
|
|
29 |
C |
p. |
artikel |
44 |
The best strategy for metastatic colorectal cancer (mCRC) patients in second-line treatment: A network meta-analysis
|
Xu, Zhili |
|
|
29 |
C |
p. |
artikel |
45 |
The clinical behavior of different molecular subtypes of breast cancer
|
Mohammed, Ayad Ahmad |
|
|
29 |
C |
p. |
artikel |
46 |
The impact of breast cancer-related lymphedema on rural and small-town Survivors’ return-to-work and quality of life: A multiple-case study
|
Anbari, Allison B. |
|
|
29 |
C |
p. |
artikel |
47 |
The impact of pathology grossing protocol measures to improve pathologic nodal staging in lung cancer
|
Ta, Robert |
|
|
29 |
C |
p. |
artikel |
48 |
Treatment patterns in non-small-cell lung cancer in China: Results from the CancerMPact survey 2020
|
Durbin, Laura |
|
|
29 |
C |
p. |
artikel |
49 |
Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usage
|
Crawford, Jeffrey |
|
|
29 |
C |
p. |
artikel |